Intellia Therapeutics
Derek brings more than 25 years of combined business, leadership and
biotechnology experience to Intellia, having most recently served as Head of
Business Development at spark Therapeutics. While at spark, he was
responsible for business development strategy, search and evaluation,
licensing and key partnership activities. Prior to this role, Mr. Hicks spent 18
years at Pfizer in a variety of business and corporate development roles
culminating with his position as Vice President, Corporate Development,
Worldwide Business Development.
As Chief Business officer at lntellia, Derek is responsible for our overall
corporate strategy, portfolio planning and developing new business and
strategic partnerships. He holds his B.S. and M.S. in mechanical engineering
from the University of Connecticut and MBA from Indiana University, Kelley
School of Business.
This person is not in any offices
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.